General election of some party branches of the group
Release time:
2022-06-01
News from our newspaper days ago, some party branches such as the first and second party branches of the group, the Huang Ping Jianfeng party branch, and the Jianfeng pharmacy party branch respectively held party member conferences to conduct general elections.
4# May 16 , the Party branch of Huang Ping Jianfeng Cement Company held a general meeting of all Party members to review and approve the work report of the previous Party branch, comprehensively review and summarize the work of the Party branch in the past three years, and propose the next work arrangement. In accordance with the relevant provisions of the constitution of the Communist Party of China and the Interim Regulations on the election of grass-roots organizations of the Communist Party of China, the Congress elected Hu Hongwei, Qian Jiang and Yang Zhendong as members of the new Party branch by secret ballot. Immediately after the first meeting of branch members, Hu Hongwei was elected as the branch secretary, Qian Jiang as the branch deputy secretary, and Yang Zhendong as the branch group propaganda member.
5# October9 , the Party branch committee of Jianfeng Pharmacy elected Xu Junxiong, Zhuang Linfang and Lang Minxiao as members of the new branch committee through differential election. In the new branch committee, Xu Junxiong was elected as the party branch secretary, Zhuang Linfang was the deputy secretary and organization member of the party branch, and Lang Minxiao was the party branch propaganda member. 5
10 , 13 , the first party branch, retired party branch, second party branch and third party branch of the group organization successively held party branch meetings to hold a new general election of the party branch. Due to personnel changes and taking into account the actual work, the four branches were also integrated in this transition. The retired party branch was merged into the first party branch. Shi Fu, Li Xia and Xu Xufen were elected as members of the new party branch, Shi Fu was elected as secretary of the party branch, Li Xia as organization member and Xu Xufen as propaganda member. The third party branch of the agency was merged into the second party branch of the agency, and Su Dabin, Zhang Yonghe, and Chi Lifan were elected as the new party branch members, Su Dabin as the party branch secretary, Zhang Yonghe as the organization member, and Chi Lifan as the propaganda member. (Lei Jianbang
Lang Minxiao Ni Yingzhen)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31